The listing of AstraZeneca's ADSs and the Debt Securities on Nasdaq is expected to cease on 30 January, and the ordinary shares and debt securities will commence trading on the NYSE from 2 February.
iStock
This Site is Intended for Healthcare Professionals Only
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Start your day right!
Get the latest updates and insights delivered to your inbox
Abiraterone is an oral tablet consumed in empty stomach to fight prostate cancer
Getty Images
Sun Pharma has been focusing on innovation-led growth, and in 2025, it acquired Checkpoint Therapeutics, an immunotherapy and targeted oncology company, for $416 million.
Sun Pharma
The Boots’ first regional dispensing hub aims to grow prescription items and healthcare services
Getty Images
×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at
data@amg.biz
to see how we manage and store your data.
×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.